Amy Emerson

Chief Executive Officer at Lykos Therapeutics (formerly MAPS PBC)

Amy Emerson is the Chief Executive Officer at Lykos Therapeutics. Prior to this role, Amy served as the MAPS PBC Executive Director and Head of Clinical Development and Regulatory Affairs at the Multidisciplinary Association for Psychedelic Studies. With a background in clinical research and management at companies such as Novartis and Chiron Corporation, Amy brings a wealth of experience to her current leadership position. She holds a Bachelor of Science degree in Genetics from Washington State University.

Links

Previous companies

Novartis logo

Timeline

  • Chief Executive Officer

    January, 2024 - present

  • MAPS PBC Executive Director And Head Of Clinical Development And Regulatory Affairs

    June, 2015